Chidamide triggers chromatin remodeling by inhibiting the relevant HDAC isoform to increase the level of acetylation of chromatin histones, and thus produces epigenetic alterations, which in turn inhibits the tumor cell cycle and induces apoptosis. The gene discussed is HDAC9; the disease is neoplasm.